Product Information
TETRACYCLINE 250 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.2691 per EA under NDC 69238152201. Its NADAC has been published 368 times since Jun 12, 2019.
Strength
250 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238152201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TETRACYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210674On Market Since
9/21/2018
Pharmacological Classes
Price Statistics
The NADAC for TETRACYCLINE 250 MG CAPSULE has been published 368 times since Jun 12, 2019, and over the history we have for it it has declined 89.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2691 per EA |
|---|---|
| All-time high | $2.5964 (Aug 14, 2019) |
| All-time low | $0.2691 (Jun 17, 2026) |
| 52-week high | $0.7024 |
| 52-week low | $0.2691 |
| Median price | $0.7685 |
| Average price | $0.8864 |
| Largest weekly change | +72.0% (Sep 22, 2021) |
| Weeks tracked | 368 |
| Tracking since | Jun 12, 2019 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TETRACYCLINE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TETRACYCLINE 250 MG CAPSULE, manufactured by Amneal Pharmaceuticals NY LLC, is $0.2691 per EA (NDC 69238152201), effective Jun 24, 2026.
How has the price of TETRACYCLINE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TETRACYCLINE 250 MG CAPSULE has declined 89.2%. It has been tracked across 368 weekly CMS publications since Jun 12, 2019.
What are the highest and lowest recorded NADAC prices for TETRACYCLINE 250 MG CAPSULE?
Since Jun 12, 2019, the NADAC for TETRACYCLINE 250 MG CAPSULE has ranged from a low of $0.2691 (Jun 17, 2026) to a high of $2.5964 (Aug 14, 2019), with a median of $0.7685 per EA.
Are there cheaper alternatives to TETRACYCLINE 250 MG CAPSULE?
4 NADAC-published products share the same active ingredient, strength, and dosage form as TETRACYCLINE 250 MG CAPSULE, but none are currently priced below it.
Who manufactures TETRACYCLINE 250 MG CAPSULE?
TETRACYCLINE 250 MG CAPSULE (NDC 69238152201) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification